Gina Mazzariello, Chief Legal Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 10,455 shares at $1.88 ($20K) on 2024-05-15, disclosed to the SEC on 2024-05-16.
Scheduled sale ($20k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2026-03-04 | $99K | — | Filing → |
| AMLX | SELL | 2026-02-25 | $48K | — | Filing → |
| AMLX | SELL | 2026-02-04 | $51K | — | Filing → |